Indaptus Therapeutics, Inc. (INDP) Q3 Net Loss Falls to $1.0M From $3.0M

Indaptus reported Q3 2026 net loss of approximately $1.0M, versus $3.0M in Q3 2025. Cash, cash equivalents and short-term investments were approximately $30.6M at September 30, 2026; $20.5M in private-placement proceeds received in Q3 were recorded as pending share issuance.Material DetailsContext…